DE69607034D1 - Pcna bindende substanz - Google Patents
Pcna bindende substanzInfo
- Publication number
- DE69607034D1 DE69607034D1 DE69607034T DE69607034T DE69607034D1 DE 69607034 D1 DE69607034 D1 DE 69607034D1 DE 69607034 T DE69607034 T DE 69607034T DE 69607034 T DE69607034 T DE 69607034T DE 69607034 D1 DE69607034 D1 DE 69607034D1
- Authority
- DE
- Germany
- Prior art keywords
- fen1
- pcna
- fragments
- binding substance
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9509557.6A GB9509557D0 (en) | 1995-05-11 | 1995-05-11 | PCNA binding substance |
PCT/GB1996/001056 WO1996035715A2 (en) | 1995-05-11 | 1996-05-02 | Pcna binding substance |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69607034D1 true DE69607034D1 (de) | 2000-04-13 |
DE69607034T2 DE69607034T2 (de) | 2000-08-03 |
Family
ID=10774309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69607034T Expired - Fee Related DE69607034T2 (de) | 1995-05-11 | 1996-05-02 | Pcna bindende substanz |
Country Status (10)
Country | Link |
---|---|
US (1) | US6613878B1 (de) |
EP (1) | EP0871655B1 (de) |
JP (1) | JPH11504933A (de) |
KR (1) | KR19990008407A (de) |
AT (1) | ATE190318T1 (de) |
AU (1) | AU705096B2 (de) |
CA (1) | CA2218327A1 (de) |
DE (1) | DE69607034T2 (de) |
GB (1) | GB9509557D0 (de) |
WO (1) | WO1996035715A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935797A (en) * | 1994-06-16 | 1999-08-10 | Stanford University | Interaction of MHC Class II proteins with members of the PCNA family of proteins |
DE69736351T4 (de) | 1996-05-08 | 2009-07-23 | Cyclacel Ltd. | Methoden und mittel zur hemmung der cdk4-aktivität |
AU6412098A (en) * | 1997-03-14 | 1998-10-12 | University Court Of The University Of Glasgow, The | Methods for identifying cell cycle regulators |
US7166475B2 (en) * | 1999-02-26 | 2007-01-23 | Cyclacel Ltd. | Compositions and methods for monitoring the modification state of a pair of polypeptides |
GB9928323D0 (en) * | 1999-11-30 | 2000-01-26 | Cyclacel Ltd | Peptides |
US7449544B2 (en) | 1999-11-30 | 2008-11-11 | Cyclacel Limited | p21 peptides |
GB0012528D0 (en) * | 2000-05-23 | 2000-07-12 | Univ Palackeho | Triterpenoid derivatives |
GB0030378D0 (en) | 2000-12-13 | 2001-01-24 | Cyclacel Ltd | Compound |
US7294471B2 (en) | 2002-02-27 | 2007-11-13 | Cskeys, Llc | Method for purifying cancer-specific proliferating cell nuclear antigen |
EA200801847A1 (ru) * | 2006-02-17 | 2009-02-27 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | ПЕПТИДНОЕ ИНГИБИРОВАНИЕ ВЗАИМОДЕЙСТВИЯ caPCNA ПРИ РАКЕ |
GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
WO2011104309A1 (en) * | 2010-02-24 | 2011-09-01 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compounds for the treatment of inflammation and neutropenia |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5596079A (en) | 1991-12-16 | 1997-01-21 | Smith; James R. | Mimetics of senescent cell derived inhibitors of DNA synthesis |
WO1995006415A1 (en) | 1993-08-30 | 1995-03-09 | Baylor College Of Medicine | Senescent cell-derived inhibitors of dna synthesis |
US5302706A (en) | 1991-12-16 | 1994-04-12 | Baylor College Of Medicine | Senescent cell derived inhibitors of DNA synthesis |
JP3485186B2 (ja) | 1992-10-16 | 2004-01-13 | コールド・スプリング・ハーバー・ラボラトリー | サイクリン複合体の転位およびそれに関連する使用 |
GB9422175D0 (en) | 1994-11-03 | 1994-12-21 | Univ Dundee | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof |
-
1995
- 1995-05-11 GB GBGB9509557.6A patent/GB9509557D0/en active Pending
-
1996
- 1996-05-02 CA CA002218327A patent/CA2218327A1/en not_active Abandoned
- 1996-05-02 JP JP8533854A patent/JPH11504933A/ja active Pending
- 1996-05-02 US US08/945,645 patent/US6613878B1/en not_active Expired - Fee Related
- 1996-05-02 AU AU55083/96A patent/AU705096B2/en not_active Ceased
- 1996-05-02 KR KR1019970707934A patent/KR19990008407A/ko not_active Application Discontinuation
- 1996-05-02 EP EP96912142A patent/EP0871655B1/de not_active Expired - Lifetime
- 1996-05-02 WO PCT/GB1996/001056 patent/WO1996035715A2/en not_active Application Discontinuation
- 1996-05-02 DE DE69607034T patent/DE69607034T2/de not_active Expired - Fee Related
- 1996-05-02 AT AT96912142T patent/ATE190318T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH11504933A (ja) | 1999-05-11 |
CA2218327A1 (en) | 1996-11-14 |
EP0871655A2 (de) | 1998-10-21 |
US6613878B1 (en) | 2003-09-02 |
DE69607034T2 (de) | 2000-08-03 |
WO1996035715A2 (en) | 1996-11-14 |
AU5508396A (en) | 1996-11-29 |
ATE190318T1 (de) | 2000-03-15 |
WO1996035715A3 (en) | 1996-12-27 |
EP0871655B1 (de) | 2000-03-08 |
KR19990008407A (ko) | 1999-01-25 |
GB9509557D0 (en) | 1995-07-05 |
AU705096B2 (en) | 1999-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
DE69334266D1 (de) | Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate | |
EA199900939A1 (ru) | Остеопротегерин-связывающие белки и рецепторы | |
IL101728A0 (en) | Human notch and delta,binding domains in toporhythmic proteins,and methods based thereon | |
DE69838143D1 (de) | Antimikrobielle peptide | |
NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
ATE190318T1 (de) | Pcna bindende substanz | |
RU93045577A (ru) | Слитные полипептиды | |
DE69516416D1 (de) | Feststellung der wechselwirkungsstelle zwischen p21-waf und pcna und deren therapeutischen verwendungen | |
ATE290315T1 (de) | Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits | |
ATE286974T1 (de) | Therapeutische domänen des von willebrand-faktor | |
DE3584775D1 (de) | Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken. | |
ATE251886T1 (de) | Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit | |
BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
BR9510067A (pt) | Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo | |
DE69940927D1 (de) | PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT | |
NO922421D0 (no) | Collagenbindende protein, samt fremstilling derav | |
PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
AU2676399A (en) | Novel cystine knot protein and materials and methods for making it | |
GB2357507A (en) | Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants | |
DE59208025D1 (de) | Neue thrombininhibitorische proteine aus landblutegeln | |
WO2002021138A3 (de) | Die m30-genfamilie und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |